- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07531836
Multicomponent Prehabilitatie bij Oudere Volwassenen met Borstkanker (PREHAB-BC65)
Multidimensional Oncogeriatric Prehabilitation in Older Adults With Breast Cancer: A Randomized Controlled Trial Integrating Frailty and Biomarker Assessment
Older adults with breast cancer frequently present with frailty, decreased functional reserve, and increased risk of postoperative complications. Prehabilitation programs have emerged as a promising strategy to improve physical function and clinical outcomes; however, evidence in geriatric oncology remains limited, particularly regarding the role of biological markers in predicting response to such interventions.
This study aims to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, focusing on functional status, clinical outcomes, and quality of life. In addition, the study seeks to characterize biological markers associated with frailty and treatment response, with the goal of identifying potential predictors of benefit from prehabilitation.
Participants will undergo a structured prehabilitation intervention including physical exercise, nutritional optimization, and comprehensive geriatric assessment. Clinical, functional, and biomarker data will be collected longitudinally.
The results of this study may contribute to improving personalized care strategies in geriatric oncology and to identifying patients who are most likely to benefit from prehabilitation programs.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
This study is a prospective, randomized, controlled, single-blind clinical trial designed to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, incorporating biological characterization to explore predictors of treatment response.
The trial will be conducted at the Navarre University Hospital (Pamplona, Spain). A total of 90 ambulatory patients aged 65 years or older with a confirmed diagnosis of breast cancer will be recruited and randomly assigned in a 1:1:1 ratio to usual care, a home-based multicomponent exercise program based on the Vivifrail methodology, or a supervised hospital-based intervention. All participants will undergo baseline frailty screening followed by a comprehensive geriatric assessment to characterize functional, cognitive, nutritional, and clinical status. Assessments will be repeated at predefined time points throughout the perioperative period and during follow-up.
The intervention is structured into preoperative and postoperative phases and includes individualized multicomponent exercise, nutritional optimization, and targeted management of geriatric syndromes. The hospital-based intervention consists of supervised sessions over six weeks (including a 2-week preoperative phase and a 4-week postoperative phase), while the home-based intervention is adapted to baseline functional status.
Clinical, functional, and biological data will be collected longitudinally to evaluate the impact of the intervention and to identify predictors of clinical outcomes and treatment response.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Marta Lorente Escudero, MD
- Telefoonnummer: +34 648148503
- E-mail: marta.lorente.escudero@navarra.es
Studie Contact Back-up
- Naam: Nicolás Martínez Velilla, PhD
- Telefoonnummer: +34 670900434
- E-mail: nicolas.martinez.velilla@navarra.es
Studie Locaties
-
-
Navarre
-
Pamplona, Navarre, Spanje, 31008
- Werving
- Hospital Universitario de Navarra
-
Contact:
- Marta Lorente Escudero, MD
- Telefoonnummer: +34 648148503
- E-mail: marta.lorente.escudero@navarra.es
-
Contact:
- Nicolás Martínez Velilla, MD, PhD
- Telefoonnummer: +34 670900434
- E-mail: nicolas.martinez.velilla@navarra.es
-
Hoofdonderzoeker:
- Nicolás Martínez Velilla, MD, PhD
-
Onderonderzoeker:
- Bernardo Abel Cedeño Veloz, MD, PhD
-
Onderonderzoeker:
- Susana de la Cruz Sánchez, MD
-
Onderonderzoeker:
- Sara Esteban Gordillo, MD
-
Onderonderzoeker:
- Natalia Moras Pérez, MD
-
Onderonderzoeker:
- Fabricio Zambom Ferraresi, PhD
-
Onderonderzoeker:
- Marta Lorente Escudero, MD
-
Onderonderzoeker:
- Lucía Lozano Vicario, MD, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Age ≥65 years
- Diagnosis of breast cancer requiring elective surgery with curative intent
- Candidate for prehabilitation program before surgery
- Ability to walk (with or without assistive devices)
- Ability to provide informed consent
Exclusion Criteria:
- Urgent or emergency surgery
- Severe cognitive impairment precluding participation in the intervention
- Severe functional dependency (e.g., bedridden patients)
- Medical contraindication to physical exercise
- Life expectancy <3 months
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Usual Care
Participants receive standard clinical care according to routine practice, including management by oncology and surgical teams. Identified geriatric conditions are communicated to the treating physician for appropriate management. |
|
|
Experimenteel: Home-based Multicomponent Prehabilitation (Vivifrail)
Participants perform a home-based multicomponent exercise program based on the Vivifrail methodology, including strength, endurance, balance, and flexibility training over six weeks, comprising a 2-week preoperative phase and a 4-week postoperative phase. The program is tailored according to baseline functional status and supported by caregiver supervision. Participants also receive comprehensive geriatric assessment and nutritional optimization. |
Participants perform a structured home-based multicomponent exercise program based on the Vivifrail methodology, including strength, endurance, balance, and flexibility training over six weeks. The program is individualized according to baseline functional status. Participants undergo comprehensive geriatric assessment with targeted interventions including nutritional optimization, medication review, and management of geriatric syndromes. |
|
Experimenteel: Supervised Multicomponent Prehabilitation
Participants receive a supervised multicomponent exercise program delivered in the hospital setting, including aerobic, resistance, balance, and flexibility training over six weeks, including a 2-week preoperative phase and a 4-week postoperative phase. The intervention is combined with comprehensive geriatric assessment, nutritional optimization, and individualized management of geriatric syndromes. |
Participants undergo comprehensive geriatric assessment with targeted interventions including nutritional optimization, medication review, and management of geriatric syndromes. Participants receive a structured, supervised multicomponent exercise program delivered in a hospital setting, including aerobic, strength, balance, and flexibility training over six weeks. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in physical function assessed by Short Physical Performance Battery (SPPB)
Tijdsspanne: Baseline to the end of the 6-week intervention period
|
Physical function will be assessed using the Short Physical Performance Battery (SPPB), a validated tool in older adults (score range 0-12, higher scores indicate better performance). The primary outcome will be the change in SPPB score from baseline to the end of the 6-week intervention period. |
Baseline to the end of the 6-week intervention period
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Incidence of postoperative complications
Tijdsspanne: Within 30 days after surgery
|
Occurrence of postoperative complications within 30 days after surgery, classified according to the Clavien-Dindo classification. |
Within 30 days after surgery
|
|
Length of hospital stay
Tijdsspanne: From date of surgery until hospital discharge, with a maximum follow-up of 30 days postoperatively
|
Number of days from surgery to hospital discharge. |
From date of surgery until hospital discharge, with a maximum follow-up of 30 days postoperatively
|
|
Functional decline after surgery
Tijdsspanne: Baseline to 30 days after surgery
|
Functional decline defined as a decrease in the Short Physical Performance Battery (SPPB) score (range 0 to 12, with higher scores indicating better physical performance) or loss of independence in activities of daily living compared to baseline. |
Baseline to 30 days after surgery
|
|
Health-related quality of life
Tijdsspanne: Baseline to 30 days after surgery
|
Health-related quality of life assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30; scores transformed to a 0-100 scale, where higher scores indicate better functioning or worse symptoms depending on the domain). |
Baseline to 30 days after surgery
|
|
Adherence to the intervention
Tijdsspanne: During the 6-week intervention period
|
Percentage of prescribed exercise sessions completed by participants. |
During the 6-week intervention period
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Marta Lorente Escudero, MD, Navarre Health Service (SNS-O), Navarre University Hospital (HUN), Pamplona, Spain
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Neurologische manifestaties
- Ziekten van het zenuwstelsel
- Neuromusculaire manifestaties
- Pathologische processen
- Neoplasmata per site
- Neoplasmata
- Pathologische aandoeningen, anatomisch
- Huidziektes
- Borst ziekten
- Spieratrofie
- Atrofie
- Pathologische aandoeningen, tekenen en symptomen
- Huid- en bindweefselaandoeningen
- Tekenen en symptomen
- Kwetsbaarheid
- Borstneoplasmata
- Sarcopenie
- Kwaliteit, toegang en evaluatie van de gezondheidszorg
- Onderzoekstechnieken
- Epidemiologische methoden
- Gegevensverzameling
- Evaluatiemechanismen voor gezondheidszorg
- Kwaliteit van de gezondheidszorg
- Volksgezondheid
- Milieu en volksgezondheid
- Bevolkingskenmerken
- Gezondheidstoestand
- Demografie
- Epidemiologische metingen
- Geriatrische beoordeling
Andere studie-ID-nummers
- HUN-PREHAB-BC-65
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Individual participant data will not be shared due to data protection regulations and institutional policies. De-identified data may be available from the corresponding author upon reasonable request, subject to ethical approval and data sharing agreements.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .